North America Chronic Total Occlusion Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The North America Chronic Total Occlusion Market size is expected to reach US$ 1,904.9 Million by 2031 from US$ 1,092.5 Million in 2024. The market is estimated to record a CAGR of 8.4% from 2025 to 2031.

Executive Summary and North America Chronic Total Occlusion Market Analysis:

The chronic total occlusion market in North America is divided into the US, Canada, and Mexico. North America accounts for a significant share of the global chronic total occlusion market. The market in this region is influenced by the increasing aging population and the surging cardiovascular disease (CVD) prevalence, especially coronary artery disease (CAD). According to the 2023 Profile of Older Americans, in 2022, there were 57.8 million adults aged 65 or older in the US, including 31.9 million women and 25.9 million men. The same report also stated that heart disease remains the number one cause of death in all Americans, affecting people of all ages and particularly harming those aged 75 and above (24.1%). Technological innovations, including percutaneous coronary interventions (PCI) and dedicated chronic total occlusion (CTO) devices, enabling minimally invasive procedures, are the major drivers of the demand for CTO procedures. Medtronic, Boston Scientific, and Abbott Laboratories are the key players in the market, which emphasize creating innovative devices for CTO interventions. The US also has a high rate of adoption of these technologies because of its developed healthcare system and favorable reimbursement policies. The increasing awareness of early detection and treatment of CVDs is a major growth opportunity. In addition, growth in specialized centers and cardiology departments contributes to the enhanced availability of CTO procedures in the region.

North America Chronic Total Occlusion Market: Strategic Insights

North America Chronic Total Occlusion Market Segmentation Analysis:

• By Equipment, the North America Chronic Total Occlusion Market is segmented into Guide Wire, Coronary InterventionA, Peripheral InterventionB, Micro Catheters, Coronary InterventionC, Peripheral InterventionD, Crossing Devices, Coronary InterventionE, Peripheral InterventionF, Re-Entry Devices, Coronary InterventionG, Peripheral InterventionH, Others, Coronary InterventionI, and Peripheral InterventionJ. Guide Wire held the largest share of the market in 2024.
• By End User, the North America Chronic Total Occlusion Market is segmented into Hospitals, Ambulatory Care Centers, and Others. Hospitals held the largest share of the market in 2024.

North America Chronic Total Occlusion Market Players Density: Understanding Its Impact on Business Dynamics

The North America Chronic Total Occlusion Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Chronic Total Occlusion Market Outlook

The rising geriatric population is a key growth driver of the chronic total occlusion (CTO) market. As the world population grows older, cardiovascular diseases become more common. According to the US Census Bureau, the number of Americans aged 65 and above is expected to increase from 58 million in 2022 to 82 million by 2050, which is a 47% increase. The percentage of the population aged 65 and older is expected to increase from 17% to 23% by 2050. According to Statistics Canada, in 2022, around one in five Canadians (18.8% of the population; 7,329,910 people) were at least 65 years of age.

According to the World Health Organization (WHO), by 2030, one in six people worldwide will be 60 years old or older. This number is projected to rise from 1 billion in 2020 to 1.4 billion in 2030 and 2.1 billion by 2050. The number of people aged 80 or older is expected to triple between 2020 and 2050 to reach 426 million. WHO also stated that by 2050, 80% of older people will be living in low- and middle-income countries. Older adults, particularly those over 60 years of age, are at higher risk of cardiovascular disease due to age-related changes in the cardiovascular system, such as decreased blood vessel elasticity and arterial plaque. The growing elderly population worldwide is driving the need for efficient and minimally invasive treatments, such as percutaneous coronary intervention (PCI) for chronic total occlusion (CTO). Older adults often struggle to adjust to traditional surgical methods, which is why there is a rising preference for minimally invasive procedures that promote faster recovery and reduce risk. This is a phenomenon that can be seen in countries with high aging populations, such as the US, Japan, and European nations. Market players such as Boston Scientific, Abbott Laboratories, and Medtronic are also more inclined to develop sophisticated CTO devices specifically designed for the aging population. These devices make treatments available, effective, and safe for this vulnerable group.

North America Chronic Total Occlusion Market Country Insights

By country, the North America Chronic Total Occlusion Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2024.

The US chronic total occlusion market is growing with the rising incidence of CVD, especially CAD, in the aging population. The American Heart Association's (AHA) 2023 Heart Disease and Stroke Statistics Update mentions that approximately 18.2 million adults in the country had CAD. The adoption of minimally invasive methods, including percutaneous coronary intervention (PCI), and the development of sophisticated CTO-specific devices are the major driving forces for market growth. Global leaders such as Medtronic, Boston Scientific, Abbott Laboratories, and Philips Healthcare dominate the US market with their innovative devices and technologies for CTO procedures. The strong healthcare infrastructure, reimbursement policies, and burgeoning emphasis on enhancing patient outcomes also fuel market growth. The growing number of specialized centers and well-trained cardiologists favors the application of CTO procedures. As per the Division of Occupational Employment and Wage Statistics, there were 15,190 employed cardiologists in the US as of 2023. In addition, growing consciousness about cardiovascular health and the detection of CTO at an early stage fuels the demand for these interventions.

North America Chronic Total Occlusion Market Company Profiles

Some of the key players operating in the market include Abbott Laboratories, Terumo Corp, Boston Scientific Corp, Medtronic Plc, Koninklijke Philips NV, Integer Holdings Corp, Becton, Dickinson and Co, Cordis Corp, Asahi Intecc Co Ltd, and SoundBite Medical Solutions.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Chronic Total Occlusion Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise